166 related articles for article (PubMed ID: 20413880)
21. Further extension of the H1 haplotype associated with progressive supranuclear palsy.
Pastor P; Ezquerra M; Tolosa E; Muñoz E; Martí MJ; Valldeoriola F; Molinuevo JL; Calopa M; Oliva R
Mov Disord; 2002 May; 17(3):550-6. PubMed ID: 12112206
[TBL] [Abstract][Full Text] [Related]
22. High-density SNP haplotyping suggests altered regulation of tau gene expression in progressive supranuclear palsy.
Rademakers R; Melquist S; Cruts M; Theuns J; Del-Favero J; Poorkaj P; Baker M; Sleegers K; Crook R; De Pooter T; Bel Kacem S; Adamson J; Van den Bossche D; Van den Broeck M; Gass J; Corsmit E; De Rijk P; Thomas N; Engelborghs S; Heckman M; Litvan I; Crook J; De Deyn PP; Dickson D; Schellenberg GD; Van Broeckhoven C; Hutton ML
Hum Mol Genet; 2005 Nov; 14(21):3281-92. PubMed ID: 16195395
[TBL] [Abstract][Full Text] [Related]
23. Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains.
Ingelsson M; Ramasamy K; Russ C; Freeman SH; Orne J; Raju S; Matsui T; Growdon JH; Frosch MP; Ghetti B; Brown RH; Irizarry MC; Hyman BT
Acta Neuropathol; 2007 Nov; 114(5):471-9. PubMed ID: 17721707
[TBL] [Abstract][Full Text] [Related]
24. Genome-wide survey of copy number variants finds MAPT duplications in progressive supranuclear palsy.
Chen Z; Chen JA; Shatunov A; Jones AR; Kravitz SN; Huang AY; Lawrence L; Lowe JK; Lewis CM; Payan CAM; Lieb W; Franke A; Deloukas P; Amouyel P; Tzourio C; Dartigues JF; ; Ludolph A; Bensimon G; Leigh PN; Bronstein JM; Coppola G; Geschwind DH; Al-Chalabi A
Mov Disord; 2019 Jul; 34(7):1049-1059. PubMed ID: 31059154
[TBL] [Abstract][Full Text] [Related]
25. GBA-associated parkinsonism and dementia: beyond α-synucleinopathies?
Pilotto A; Schulte C; Hauser AK; Biskup S; Munz M; Brockmann K; Schaeffer E; Synofzik M; Maetzler W; Suenkel U; Srulijes K; Gasser T; Berg D
Eur J Neurol; 2016 Mar; 23(3):520-6. PubMed ID: 26549049
[TBL] [Abstract][Full Text] [Related]
26. A combination of CSF tau ratio and midsaggital midbrain-to-pons atrophy for the early diagnosis of progressive supranuclear palsy.
Borroni B; Malinverno M; Gardoni F; Grassi M; Parnetti L; Agosti C; Alberici A; Premi E; Bonuccelli U; Gasparotti R; Calabresi P; Di Luca M; Padovani A
J Alzheimers Dis; 2010; 22(1):195-203. PubMed ID: 20847421
[TBL] [Abstract][Full Text] [Related]
27. Screening for MAPT and PGRN mutations in Korean patients with PSP/CBS/FTD.
Kim HJ; Jeon BS; Yun JY; Seong MW; Park SS; Lee JY
Parkinsonism Relat Disord; 2010 May; 16(4):305-6. PubMed ID: 20171924
[No Abstract] [Full Text] [Related]
28. H1 haplotype of the MAPT gene is associated with lower regional gray matter volume in healthy carriers.
Canu E; Boccardi M; Ghidoni R; Benussi L; Testa C; Pievani M; Bonetti M; Binetti G; Frisoni GB
Eur J Hum Genet; 2009 Mar; 17(3):287-94. PubMed ID: 18854867
[TBL] [Abstract][Full Text] [Related]
29. Assessment of serum uric acid as risk factor for tauopathies.
Schirinzi T; Di Lazzaro G; Colona VL; Imbriani P; Alwardat M; Sancesario GM; Martorana A; Pisani A
J Neural Transm (Vienna); 2017 Sep; 124(9):1105-1108. PubMed ID: 28620833
[TBL] [Abstract][Full Text] [Related]
30. The PSP-associated MAPT H1 subhaplotype in Guadeloupean atypical parkinsonism.
Camuzat A; Romana M; Dürr A; Feingold J; Brice A; Ruberg M; Lannuzel A
Mov Disord; 2008 Dec; 23(16):2384-91. PubMed ID: 18785640
[TBL] [Abstract][Full Text] [Related]
31. Relationship between frontotemporal dementia and corticobasal degeneration/progressive supranuclear palsy.
Kertesz A; Munoz D
Dement Geriatr Cogn Disord; 2004; 17(4):282-6. PubMed ID: 15178937
[TBL] [Abstract][Full Text] [Related]
32. Association of MAPT haplotype-tagging SNPs with sporadic Parkinson's disease.
Vandrovcova J; Pittman AM; Malzer E; Abou-Sleiman PM; Lees AJ; Wood NW; de Silva R
Neurobiol Aging; 2009 Sep; 30(9):1477-82. PubMed ID: 18162161
[TBL] [Abstract][Full Text] [Related]
33. Intrafamilial variable phenotype including corticobasal syndrome in a family with p.P301L mutation in the MAPT gene: first report in South America.
Gatto EM; Allegri RF; Da Prat G; Chrem Mendez P; Hanna DS; Dorschner MO; Surace EI; Zabetian CP; Mata IF
Neurobiol Aging; 2017 May; 53():195.e11-195.e17. PubMed ID: 28268100
[TBL] [Abstract][Full Text] [Related]
34. Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy.
Kouri N; Ross OA; Dombroski B; Younkin CS; Serie DJ; Soto-Ortolaza A; Baker M; Finch NCA; Yoon H; Kim J; Fujioka S; McLean CA; Ghetti B; Spina S; Cantwell LB; Farlow MR; Grafman J; Huey ED; Ryung Han M; Beecher S; Geller ET; Kretzschmar HA; Roeber S; Gearing M; Juncos JL; Vonsattel JPG; Van Deerlin VM; Grossman M; Hurtig HI; Gross RG; Arnold SE; Trojanowski JQ; Lee VM; Wenning GK; White CL; Höglinger GU; Müller U; Devlin B; Golbe LI; Crook J; Parisi JE; Boeve BF; Josephs KA; Wszolek ZK; Uitti RJ; Graff-Radford NR; Litvan I; Younkin SG; Wang LS; Ertekin-Taner N; Rademakers R; Hakonarsen H; Schellenberg GD; Dickson DW
Nat Commun; 2015 Jun; 6():7247. PubMed ID: 26077951
[TBL] [Abstract][Full Text] [Related]
35. Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome.
Tsuboi Y; Josephs KA; Boeve BF; Litvan I; Caselli RJ; Caviness JN; Uitti RJ; Bott AD; Dickson DW
Mov Disord; 2005 Aug; 20(8):982-8. PubMed ID: 15834857
[TBL] [Abstract][Full Text] [Related]
36. Study of LRRK2 variation in tauopathy: Progressive supranuclear palsy and corticobasal degeneration.
Sanchez-Contreras M; Heckman MG; Tacik P; Diehl N; Brown PH; Soto-Ortolaza AI; Christopher EA; Walton RL; Ross OA; Golbe LI; Graff-Radford N; Wszolek ZK; Dickson DW; Rademakers R
Mov Disord; 2017 Jan; 32(1):115-123. PubMed ID: 27709685
[TBL] [Abstract][Full Text] [Related]
37. A lack of the R406W tau mutation in progressive supranuclear palsy and corticobasal degeneration.
Higgins JJ; Litvan I; Nee LE; Loveless JM
Neurology; 1999 Jan; 52(2):404-6. PubMed ID: 9932968
[TBL] [Abstract][Full Text] [Related]
38. Genetic determinants of survival in progressive supranuclear palsy: a genome-wide association study.
Jabbari E; Koga S; Valentino RR; Reynolds RH; Ferrari R; Tan MMX; Rowe JB; Dalgard CL; Scholz SW; Dickson DW; Warner TT; Revesz T; Höglinger GU; Ross OA; Ryten M; Hardy J; Shoai M; Morris HR;
Lancet Neurol; 2021 Feb; 20(2):107-116. PubMed ID: 33341150
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP.
Josephs KA; Petersen RC; Knopman DS; Boeve BF; Whitwell JL; Duffy JR; Parisi JE; Dickson DW
Neurology; 2006 Jan; 66(1):41-8. PubMed ID: 16401843
[TBL] [Abstract][Full Text] [Related]
40. 5'-Upstream variants of CRHR1 and MAPT genes associated with age at onset in progressive supranuclear palsy and cortical basal degeneration.
Cruchaga C; Vidal-Taboada JM; Ezquerra M; Lorenzo E; Martinez-Lage P; Blazquez M; Tolosa E; ; Pastor P
Neurobiol Dis; 2009 Feb; 33(2):164-70. PubMed ID: 19022385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
